Q4 2024 Management View CEO Jacob Thaysen highlighted the transformative progress Illumina made in 2024, emphasizing its strategic roadmap targeting high single-digit revenue growth by 2027. He noted ...

KUNMING -- Chinese researchers have recently discovered that unique DNA methylation characteristics in long-lived men grant ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

Illumina's (ILMN) stock slid 5% post-market after it released its Q4 earnings report and reiterated its 2025 guidance, despite the company facing potential sanctions in China.

Electric-truck maker Nikola is nearing filing for a bankruptcy, the Wall Street Journal reported on Thursday, citing people ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

UC Santa Cruz genomics experts gained new insights into the campus's endearingly eccentric mascot — and overcame the unique ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

Could a novel approach to genetic studies give us a clearer picture of how evolutionary adaptations occur? That's what the ...

With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace ...

Harwood works with technology and business leaders to respond to rapid innovation at the intersection of science and technology. His research explores the rise of generative AI and accelerated use of ...

Two rare bird flu strains have emerged since late January, prompting public health concerns during a freeze on federal health communications.